Detailed Product Description
Trityl Olmesartan - US$600/Kg
Olmesartan - US$1000/Kg
We can share the Open-part of DMF on signing CDA. W have filed USDMF & EDMF.
Olmesartan acts as an anti-hypertension agent. Olmesartan blocks the vasoconstrictor effects of angiotensin II by selectively blocking the binding of angiotensin II to the AT 1 receptor in vascular smooth muscle. Its action is, therefore, independent of the pathways for angiotensin II synthesis. Olmesartan has more than a 12,500-fold greater affinity for the AT 1 receptor than for the AT 2 receptor.
Olmesartan medoxomil does not inhibit ACE (kininase II), hence it does not affect the response to bradykinin.
I have attached the COA and Specs for Olmesartan Medoxomil. Our Manufacturing Capacity is 1.2Mt/Month.
We are currently supplying to all major Pharma companies. Looking forward for your business cooperation. Thanks.
The patent for Olmesartan is expiring in 2016 worldwide and we are following a non-patent infringing process.
We are currently the biggest manufacturers of Olmesartan in India selling over 600Kgs/month. The current API pricing is above USD1500/Kg.
We have two grades in Olmesartan catering to different markets; we would like to know which grade you prefer.
Olmesartan Medoxomil >99% -- USD900/Kg (Single Impurity NMT 0.5% and Total Impurity NMT 1.0%)
Olmesartan Medoxomil ICH -- USD1330/Kg(Single Unknown Impurity NMT 0.1% and Total Impurity NMT 1.0%)
Looking forward for your kind feedback.